>>421
ここ↓風説の流布にあたらんか？

Sosei has penned similar deals before, including a 2016 pact with then Allergan, now, ironically, AbbVie, worth up to $3.3 billion in biobucks and with a focus on Alzheimer’s, although one drug from that original partnership has already been pulled.